Thrombosis Research
Volume 121, Issue 3 , Pages 293-299, 2007

Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction

  • Alberto Dominguez-Rodriguez

      Affiliations

    • Department of Cardiology (Coronary Care Unit), Hospital Universitario de Canarias, Tenerife, Spain
    • Corresponding Author InformationCorresponding author. Coronary Care Unit, University Hospital of Canarias, Ofra s/n La Cuesta E-38320, Tenerife, Spain. Tel.: +34 922 679030; fax: +34 922 362716.
    • ,
  • Pedro Abreu-Gonzalez

      Affiliations

    • Department of Physiology, University of La Laguna, School of Medicine, Tenerife, Spain
    • ,
  • Martín J. Garcia-Gonzalez

      Affiliations

    • Department of Cardiology (Coronary Care Unit), Hospital Universitario de Canarias, Tenerife, Spain
    • ,
  • Juan Carlos Kaski

      Affiliations

    • Cardiovascular Biology Research Centre, Division of Cardiac and Vascular Sciences, St. George's, University of London, London, United Kingdom

Received 5 March 2007; received in revised form 10 April 2007; accepted 12 April 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0049-3848(07)00178-8

doi:10.1016/j.thromres.2007.04.007

Thrombosis Research
Volume 121, Issue 3 , Pages 293-299, 2007

Article Tools

* Image Usage & Resolution